Nick A. Maskell
Impact in
-
- Ultrasound in Clinical Applications
- Pulmonary and Respiratory Medicine top 0.1%
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Lung Cancer Diagnosis and Treatment
- Pneumothorax, Barotrauma, Emphysema
Papers in
-
- Pleural and Pulmonary Diseases 201
- Occupational and environmental lung diseases 69
- Lung Cancer Diagnosis and Treatment 34
- Pneumothorax, Barotrauma, Emphysema 29
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 15
- Medical Imaging and Pathology Studies 11
-
- Ultrasound in Clinical Applications 52
- Co-authors
- Clare E. Hooper (17 shared papers)Yun Chor Gary Lee (23 shared papers)Rahul Bhatnagar (43 shared papers)John Harvey (11 shared papers)Najib Mahboob Rahman (62 shared papers)Anthony Edey (21 shared papers)Anna Morley (14 shared papers)Robert J.O. Davies (11 shared papers)
- Journals
- Thorax (32 papers)European Respiratory Journal (22 papers)CHEST Journal (17 papers)BMJ Open (11 papers)American Journal of Respiratory and Critical Care Medicine (10 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Nick A. Maskell
301 papers receiving 13.3k citations
Nick A. Maskell's Hit Papers
Peers
Comparison fields: 5 of 154
- Critical Care and Intensive Care Medicine 2.2k
- Pulmonary and Respiratory Medicine 8.7k
- Internal Medicine 734
- Infectious Diseases 1.6k
- Neurology 801
Countries citing papers authored by Nick A. Maskell
This map shows the geographic impact of Nick A. Maskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick A. Maskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick A. Maskell more than expected).
Fields of papers citing papers by Nick A. Maskell
This network shows the impact of papers produced by Nick A. Maskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick A. Maskell. The network helps show where Nick A. Maskell may publish in the future.
Co-authors
The 25 scholars most cited alongside Nick A. Maskell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions Hit paper breakdown → | 2013 | 1003 |
| 2 | Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010 Hit paper breakdown → | 2010 | 588 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 5 | Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score Hit paper breakdown → | 2014 | 328 |
| 6 | Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline Hit paper breakdown → | 2018 | 309 |
| 7 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 307 |
| 8 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 9 | 2003 | 274 | |
| 10 | 2006 | 273 | |
| 11 | 2003 | 265 | |
| 12 | 2003 | 247 | |
| 13 | 2003 | 234 | |
| 14 | 2016 | 227 | |
| 15 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 16 | 2018 | 205 | |
| 17 | 2004 | 186 | |
| 18 | 2020 | 184 | |
| 19 | 2016 | 180 | |
| 20 | 2018 | 179 |
About Nick A. Maskell
Nick A. Maskell is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Surgery, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 321 papers that have together received 13.8k indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (201 papers), Occupational and environmental lung diseases (69 papers), Ultrasound in Clinical Applications (52 papers), Lung Cancer Diagnosis and Treatment (34 papers), Pneumothorax, Barotrauma, Emphysema (29 papers), Trauma Management and Diagnosis (25 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers) and Medical Imaging and Pathology Studies (11 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (2.2k citations), Pulmonary and Respiratory Medicine (8.7k citations), Internal Medicine (734 citations), Infectious Diseases (1.6k citations) and Neurology (801 citations). Nick A. Maskell has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Clare E. Hooper, Yun Chor Gary Lee, Rahul Bhatnagar, John Harvey, Najib Mahboob Rahman, Anthony Edey, Anna Morley, Robert J.O. Davies, Mike Darby and Fergus Vincent Gleeson. Their work appears in journals such as Thorax, European Respiratory Journal, CHEST Journal, BMJ Open and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.